1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
67880FA8953CAA3E0852582A30035B1DE
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/tactics-communicating-investigator-sponsored-trials-congresses-ists-msls-involvement?opendocument
18
19opendocument
2034.229.151.87
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




Products & Services Medical Affairs Clinical Trials

Tactics for Communicating Investigator Sponsored Trials for Congresses/ ISTs and MSLs’ Involvement

ID: 5511


Features:

4 Info Graphics

9 Data Graphics

49 Metrics


Pages/Slides: 19


Published: 2018


Delivery Format: Online PDF Document


 

License Options:
close

Single User: Authorizes use by the person who places the order or for whom the order was placed.

Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.

Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.




Buy Now

 


  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
Non-members: Click here to review a complimentary excerpt from “Tactics for Communicating Investigator Sponsored Trials for Congresses/ ISTs and MSLs’ Involvement”


STUDY OVERVIEW


Scientific congresses are an important platform for the Medical Affairs function to share vital information with healthcare professionals. However, when it comes to raising awareness about Investigator Sponsored Trials (ISTs), many organizations have regulatory and compliance concerns about the type of information to be shared and the tools that can be used to raise awareness.

Best Practices, LLC undertook this benchmarking research to inform Medical Affairs leaders on the ways in which their peers share IST information in Medical Affairs booths at scientific congresses. In particular, this study provides industry benchmarks on the types of IST studies supported by organizations, tools used to raise IST awareness, reasons for not promoting ISTs proactively for congresses, caveats to legal/regulatory/compliance approval, involvement level of MSLs and key lessons learned.


KEY TOPICS

  • Types of IST Studies Supported by Organizations
  • Type of Information and Tools Used for Sharing IST Information
  • Reasons for Not Promoting ISTs Proactively for Congresses
  • Caveats to Legal/Regulatory/Compliance Approval
  • Involvement of MSLs, Permission to MSLs and Lessons Learned

KEY METRICS

  • Which of the listed tools have you used to raise awareness or advertise ISTs from your company at your Medical Affairs booth?
  • What type of information do you provide in relation to ISTs?
  • Are MSLs within your organization allowed to include in a post-conference slide deck, scientific information presented at the congress on products not owned/marketed by your company?
  • If asked unsolicited about IST data, under scientific exchange are your MSLs allowed to answer questions on products not owned/marketed by your company?

SAMPLE KEY FINDINGS

  • All companies have used MSLs to promote ISTs, at some point: Surveyed companies all said they have used MSLs at scientific congresses or while in the field to promote ISTs that will be featured at a given congress. No other tactic has been used by more than 29% (meeting brochures/program books and panels at the medical affairs booth providing an IST overview).

METHODOLOGY


Best Practices, LLC engaged 10 medical affairs leaders from 9 bio-pharmaceutical companies through a benchmarking survey instrument.


Industries Profiled:
Pharmaceutical; Biotech; Communications; Health Care; Biopharmaceutical; Clinical Research; Laboratories


Companies Profiled:
Abbvie; Allergan; ApotheCom; Ferring Pharmaceuticals; Novartis; Sanofi; Sun Pharmaceutical; Versant; Vifor Pharma


If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.